Pneumococcal vaccination in splenectomised cancer patients
Clicks: 269
ID: 112870
2005
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Steady Performance
73.6
/100
265 views
216 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
Although pneumococcal vaccination has been recommended in splenectomised patients for more than 30 years, its use remains unsatisfactory. We conducted two consecutive retrospective assessments to determine the rate of pneumococcal vaccination among splenectomised cancer patients at a single institut …
| Reference Key |
ag2005europeanpneumococcal
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Omlin AG;Mühlemann K;Fey MF;Pabst T;; |
| Journal | European journal of cancer (Oxford, England : 1990) |
| Year | 2005 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
humans
pubmed abstract
nih
national institutes of health
national library of medicine
adult
female
male
aged
middle aged
80 and over
neoplasms / complications*
pneumococcal infections / prevention & control*
pmid:16026979
doi:10.1016/j.ejca.2005.04.027
aurelius g omlin
kathrin mühlemann
thomas pabst
hodgkin disease / complications
pneumococcal vaccines*
splenectomy / adverse effects*
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.